Related Experiment Video
Updated: Jun 3, 2026

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
Chemical modification of small interfering RNA
Jesper B Bramsen1, Jørgen Kjems
1Department of Molecular Biology, Interdisciplinary Nanoscience Center (iNANO), University of Aarhus, Aarhus, Denmark. jebb@mb.au.dk
Chemically synthesized small interfering RNAs (siRNAs) require structural modifications for safe and effective in vivo gene silencing. This review guides optimizing siRNA design for enhanced stability, delivery, specificity, and reduced toxicity.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Chemically synthesized small interfering RNAs (siRNAs) are crucial for gene silencing applications.
- In vitro applications of siRNAs face fewer challenges compared to in vivo settings regarding stability, delivery, and immunogenicity.
- In vivo use of siRNAs is hindered by limited stability, unfavorable pharmacokinetics, and potential immune system side effects.
Purpose of the Study:
- To provide a guide for chemical and structural modifications of siRNAs.
- To improve siRNA activity, stability, specificity, and reduce toxicity for in vivo applications.
- To address challenges associated with off-target gene silencing.
Main Methods:
- Review of chemical modifications for siRNA structure.
- Analysis of structural design principles for enhanced siRNA performance.
- Discussion of strategies to mitigate off-target effects and immunogenicity.
Main Results:
- Chemical modifications can significantly improve siRNA stability and pharmacokinetic profiles.
- Optimized structural design enhances target specificity and reduces off-target silencing.
- Strategic modifications can minimize adverse immune responses.
Conclusions:
- Careful chemical and structural design is essential for successful in vivo siRNA therapeutics.
- Modified siRNAs offer improved safety and efficacy for gene silencing.
- This review provides a framework for developing next-generation siRNA-based therapies.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Small interfering RNAs (siRNA)
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs
